CLINICAL_TRIALS
trial_result
· 2008-04-01
Clinical Trial Update: Acute Application of Pegvisomant and Octreotide in Acromegaly [Phase 4]
Summary
A Phase 4 clinical trial update examining the acute use of pegvisomant and octreotide in patients with acromegaly.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Ludwig-Maximilians - University of Munich | Conditions: Acromegaly | Phase 4 | Status: COMPLETED